10-87709326-CATAT-C
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_001015880.2(PAPSS2):c.145+29_145+32delTATA variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.44 in 1,153,434 control chromosomes in the GnomAD database, including 99,616 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.51 ( 20090 hom., cov: 0)
Exomes 𝑓: 0.43 ( 79526 hom. )
Consequence
PAPSS2
NM_001015880.2 intron
NM_001015880.2 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.0260
Genes affected
PAPSS2 (HGNC:8604): (3'-phosphoadenosine 5'-phosphosulfate synthase 2) Sulfation is a common modification of endogenous (lipids, proteins, and carbohydrates) and exogenous (xenobiotics and drugs) compounds. In mammals, the sulfate source is 3'-phosphoadenosine 5'-phosphosulfate (PAPS), created from ATP and inorganic sulfate. Two different tissue isoforms encoded by different genes synthesize PAPS. This gene encodes one of the two PAPS synthetases. Defects in this gene cause the Pakistani type of spondyloepimetaphyseal dysplasia. Two alternatively spliced transcript variants that encode different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 10-87709326-CATAT-C is Benign according to our data. Variant chr10-87709326-CATAT-C is described in ClinVar as [Benign]. Clinvar id is 1164974.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-87709326-CATAT-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.768 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PAPSS2 | NM_001015880.2 | c.145+29_145+32delTATA | intron_variant | ENST00000456849.2 | NP_001015880.1 | |||
PAPSS2 | NM_004670.4 | c.145+29_145+32delTATA | intron_variant | NP_004661.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PAPSS2 | ENST00000456849.2 | c.145+29_145+32delTATA | intron_variant | 1 | NM_001015880.2 | ENSP00000406157.1 | ||||
PAPSS2 | ENST00000361175.8 | c.145+29_145+32delTATA | intron_variant | 1 | ENSP00000354436.4 | |||||
PAPSS2 | ENST00000465996.5 | n.167+29_167+32delTATA | intron_variant | 2 | ||||||
PAPSS2 | ENST00000482258.1 | n.188+29_188+32delTATA | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.507 AC: 75876AN: 149512Hom.: 20047 Cov.: 0
GnomAD3 genomes
AF:
AC:
75876
AN:
149512
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.430 AC: 432085AN: 1003814Hom.: 79526 AF XY: 0.433 AC XY: 223589AN XY: 516594
GnomAD4 exome
AF:
AC:
432085
AN:
1003814
Hom.:
AF XY:
AC XY:
223589
AN XY:
516594
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.508 AC: 75977AN: 149620Hom.: 20090 Cov.: 0 AF XY: 0.516 AC XY: 37650AN XY: 72968
GnomAD4 genome
AF:
AC:
75977
AN:
149620
Hom.:
Cov.:
0
AF XY:
AC XY:
37650
AN XY:
72968
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Spondyloepimetaphyseal dysplasia, PAPSS2 type Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at